Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [2] Core Views - The company has shown robust revenue growth, with a year-on-year increase of 20.13% in Q3 2024 and a cumulative revenue of 774 million yuan for the first three quarters of 2024, representing a 29.84% increase year-on-year [5] - The company is increasing its investment in the "Sports Nutrition Food Production Base Construction Project," raising the planned investment from 126 million yuan to 309 million yuan due to rapid market demand for solid and liquid products [6] - The company is expected to benefit from the high demand in the sports nutrition industry, with a strong competitive edge in product quality and channel distribution [7] Financial Performance - The company achieved a net profit of 66 million yuan in the first three quarters of 2024, a 2.06% increase year-on-year, while the non-recurring net profit rose by 27.25% to 65 million yuan [5] - The gross profit margin for Q3 2024 was 37.64%, down 3.18 percentage points year-on-year, primarily due to rising raw material costs [6] - The company forecasts revenues of 1,001 million yuan for 2024, with a year-on-year growth of 18.8%, and net profits of 98 million yuan, reflecting an 11% increase [10] Valuation and Earnings Forecast - The estimated earnings per share (EPS) for 2024, 2025, and 2026 are projected to be 0.79 yuan, 0.99 yuan, and 1.25 yuan respectively [10] - The company is assigned a price-to-earnings (P/E) ratio of 16-20 times for 2025, leading to a reasonable valuation range of 15.84 to 19.8 yuan per share [7]
康比特：公司季报点评：收入稳健增长，扣非利润率略有下降